Patent details

300651 Product Name: Combinatie van glycopyrronium of een zout daarvan, in het bijzonder glycopyrroniumbromide, en indacaterol of een zout daarvan, in het bijzonder indacaterolmaleaat.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300651
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1267866
Status:
Refused Art. 10 of the EC Regulations
Application number:
300651
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

Marketing Authorization Number:
EU/1/13/862/001-006
Marketing Authorization Type:
EEA
Marketing Authorization Date:
19/09/2013
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
07/03/2014
First Marketing Authorization date:
19/09/2013
Grant date:
Activation date:
09/04/2021
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
07/03/2014
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
30/06/2021

Applicant/holder

From:
14/05/2019
 
 

 

Name:
Heptares Therapeutics Limited
Address:
Granta Park, Great Abington Cambridge CB21 6DG, United Kingdom (GB)

Historical Applicant/holder

From:
07/03/2014
To:
14/05/2019

 

Name:
Sosei R&D Ltd.
Address:
London Bioscience Innovation Centre, 2 Royal College Street, NW1 ONH, London, United Kingdom (GB)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
07/03/2014
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
26/21
Publication date:
30/06/2021
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
25/19
Publication date:
19/06/2019
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
SPC
Journal edition number:
2014/12
Publication date:
19/03/2014
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201900940A
Date Registered:
14/05/2019
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Heptares Therapeutics Limited
Address:
Granta Park, Great Abington Cambridge CB21 6DG, United Kingdom (GB)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:
Filing date Document type Document Description Number of pages File Type
30/06/2021 Outgoing Correspondence Decision refusal 2 PDF /1/5/6/0/0/0400300651/docs/300651_15_419954l527a.pdf
18/03/2021 Outgoing Correspondence Letter to applicant 2 PDF /1/5/6/0/0/0400300651/docs/300651_6_400682l173.pdf
23/03/2016 SPC Documents Annex SPC 2 PDF /1/5/6/0/0/0400300651/docs/300651_0_supplprotectioncertificate20200310030331368.pdf
23/03/2016 SPC Documents Annex SPC 14 PDF /1/5/6/0/0/0400300651/docs/300651_1_supplprotectioncertificate20200310030811415.pdf
23/03/2016 SPC Documents Subsequently filed documents 1 PDF /1/5/6/0/0/0400300651/docs/300651_2_supplprotectioncertificate20160331112407992.pdf
23/03/2016 SPC Documents Subsequently filed documents 1 PDF /1/5/6/0/0/0400300651/docs/300651_3_supplprotectioncertificate20160331112408090.pdf
23/03/2016 SPC Documents Annex SPC 2 PDF /1/5/6/0/0/0400300651/docs/300651_7_supplprotectioncertificate20200310030234832.pdf
23/03/2016 SPC Documents Annex SPC 4 PDF /1/5/6/0/0/0400300651/docs/300651_12_supplprotectioncertificate20200310030130160.pdf
23/03/2016 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /1/5/6/0/0/0400300651/docs/300651_13_incomingcorrespondencepaper20200310030702617.pdf
08/08/2014 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /1/5/6/0/0/0400300651/docs/300651_16_incomingcorrespondencepaper20200310023752453.pdf
18/06/2014 Outgoing Correspondence Outgoing Letter 1 PDF /1/5/6/0/0/0400300651/docs/300651_11_outgoingcorrespondence20140618.pdf
18/06/2014 Outgoing Correspondence Outgoing Letter 1 PDF /1/5/6/0/0/0400300651/docs/300651_18_outgoingcorrespondence20140618.pdf
16/06/2014 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /1/5/6/0/0/0400300651/docs/300651_4_incomingcorrespondencepaper20200310023425379.pdf
18/03/2014 Outgoing Correspondence Outgoing Letter 3 PDF /1/5/6/0/0/0400300651/docs/300651_9_outgoingcorrespondence20140318.pdf
10/03/2014 Outgoing Correspondence Outgoing Letter 1 PDF /1/5/6/0/0/0400300651/docs/300651_10_outgoingcorrespondence20140310.pdf
07/03/2014 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /1/5/6/0/0/0400300651/docs/300651_5_incomingcorrespondencepaper20140307.pdf
07/03/2014 SPC Documents Marketing Authorization SPC 3 PDF /1/5/6/0/0/0400300651/docs/300651_8_supplprotectioncertificate20200310022430088.pdf
07/03/2014 SPC Documents Summary of the characteristics of the product 24 PDF /1/5/6/0/0/0400300651/docs/300651_14_supplprotectioncertificate20200310022847894.pdf
07/03/2014 Application Form First filed application form 2 PDF /1/5/6/0/0/0400300651/docs/300651_17_applicationform20140307.pdf